Education
About Us
Working with TipRanks
Follow Us
ReposiTrak (TRAK)
NYSE:TRAK
Top Page
ReposiTrak
(NYSE:TRAK)
Select Model
Select Model
Rating:68Neutral
Price Target:
$16.00
▲(7.24% Upside)
ReposiTrak's overall stock score reflects strong financial performance and positive earnings call highlights, tempered by bearish technical indicators and high valuation concerns. The company's robust growth and financial stability are offset by current market sentiment and valuation challenges.
Positive Factors
Revenue Growth
Consistent revenue growth demonstrates expanding market reach and product adoption, indicating a strong demand for ReposiTrak's solutions.
Strong Cash Position
A robust cash position provides financial flexibility for strategic investments, supporting long-term growth and stability.
Supplier-Centric Model
The supplier-centric model enhances customer engagement and cross-selling opportunities, expanding ReposiTrak's market reach and solution adoption.
Negative Factors
Operating Expense Increase
Rising operating expenses could pressure margins and profitability, potentially impacting long-term financial performance if not managed effectively.
FDA Compliance Deadline Extension
The delay in compliance deadlines may slow the adoption of traceability solutions, affecting ReposiTrak's growth trajectory in the near term.
Decline in Free Cash Flow Growth
A decline in free cash flow growth could signal challenges in maintaining cash generation, potentially impacting ReposiTrak's ability to fund future growth initiatives.
ReposiTrak (TRAK) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$272.80M
Dividend Yield0.5%
Average Volume (3M)57.29K
Price to Earnings (P/E)43.2
Beta (1Y)1.27
Revenue Growth10.53%
EPS Growth21.98%
CountryUS
Employees73
SectorTechnology
Sector Strength88
IndustrySoftware - Application
Share Statistics
EPS (TTM)0.09
Shares Outstanding18,283,903
10 Day Avg. Volume73,273
30 Day Avg. Volume57,293
Financial Highlights & Ratios
PEG Ratio2.57
Price to Book (P/B)7.25
Price to Sales (P/S)15.87
P/FCF Ratio42.70
Enterprise Value/Market Cap1.21
Enterprise Value/Revenue14.65
Enterprise Value/Gross Profit17.50
Enterprise Value/Ebitda42.43
Forecast
1Y Price Target
$29.00Price Target Upside94.37% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
ReposiTrak Business Overview & Revenue Model
Company DescriptionReposiTrak, Inc., a software-as-a-service provider, designs, develops, and markets proprietary software products in North America. The company offers ReposiTrak MarketPlace, a supplier discovery and B2B e-commerce solution; ReposiTrak Compliance and Food Safety solutions, which reduces potential regulatory and legal risk from their supply chain partners; and ReposiTrak Supply Chain solutions that enables customers to manage relationships with suppliers. It also provides ScoreTracker, Vendor Managed Inventory, Store Level Ordering and Replenishment, Enterprise Supply Chain Planning, Fresh Market Manager, Audit Management, and ActionManager supply chain solutions to manage inventory, product mix, and labor. In addition, the company offers business-consulting services to suppliers and retailers in the grocery, convenience store, and specialty retail industries, as well as professional consulting services. It primarily serves multi-store retail chains, wholesalers and distributors, and their suppliers. The company was formerly known as Park City Group, Inc. and changed its name to ReposiTrak, Inc. in December 2023. ReposiTrak, Inc. is headquartered in Murray, Utah.
How the Company Makes MoneyReposiTrak generates revenue through a subscription-based model, where clients pay for access to its software platform and services. Key revenue streams include annual subscriptions for compliance and traceability solutions, transaction fees from the processing of product data, and consulting services aimed at helping businesses optimize their supply chain processes. Additionally, partnerships with major retailers and food industry stakeholders enhance revenue opportunities through shared compliance initiatives and data analytics services, allowing ReposiTrak to expand its market reach and strengthen its service offerings.
ReposiTrak Earnings Call Summary
Earnings Call Date:Sep 29, 2025
(Q3-2025)
| % Change Since: |
Next Earnings Date:Nov 17, 2025
Earnings Call Sentiment Positive
The earnings call reflects strong revenue and net income growth, a solid cash position, and a strategic focus on operational efficiency and future growth. However, increased operating and onboarding expenses present challenges. The company remains optimistic about its ability to grow and return capital to shareholders.Q3-2025 Updates
Positive Updates
Strong Revenue Growth
Revenue grew 16% in the third fiscal quarter to $5.9 million, and recurring revenue increased 15% to $5.8 million.
Significant Net Income Growth
Net income increased 27% from $1.6 million to $2 million, and net income to common shareholders increased 33% from $1.4 million to $1.9 million.
Cash Position and Capital Allocation
The company has over $28 million in cash at the end of the March 31 quarter and has returned over $25 million in capital to shareholders through dividends, stock repurchases, and preferred stock redemptions.
Deferred Revenue and Future Growth
Deferred revenue increased 70% to $4.2 million, indicating future revenue potential. The company remains confident in growing annual top-line revenue by 10% to 20%.
Operational Leverage and Efficiency
The company has maintained a common technology platform leading to financial and operational efficiencies, with a current revenue contribution margin of about 50%, aiming to reach 80%.
Negative Updates
Increased Operating Expenses
Operating expenses increased by 7%, due to investments in RTN, higher commissions, and increases in insurance and benefit costs for employees.
Challenges with Automation and Marketing Costs
While automation is a focus, onboarding and marketing expenses are expected to flatten over the next 12 to 20 months, indicating current high costs in these areas.
Tax Considerations
The company has about $8 million to $9 million left in net operating losses, but the exact future tax rate remains uncertain, suggesting potential higher tax liabilities.
Company Guidance
During ReposiTrak's fiscal third-quarter 2025 earnings call, the company highlighted its robust financial performance and strategic growth plans. Revenue for the quarter increased by 16% to $5.9 million, with a significant boost in net income by 27%, reaching $2 million. The company emphasized its strategy to grow annual revenue by 10% to 20% and profitability at a faster pace, evidenced by a 50% contribution margin on incremental revenue. Deferred revenue saw a 70% rise, signaling strong future prospects. ReposiTrak continues to focus on expanding its traceability, compliance, and supply chain solutions, expecting to leverage its single technology platform for operational efficiency and cross-selling opportunities. Despite increased operating expenses, the company's income from operations improved by 43%. The capital allocation strategy remains intact, with over $28 million in cash and plans to return 50% of annual cash from operations to shareholders.ReposiTrak Financial Statement Overview
Summary
ReposiTrak displays a solid financial performance across all key financial statements. The company has shown strong revenue growth and profitability, supported by a stable and efficient balance sheet and robust cash flow generation. This indicates a well-managed company with a positive outlook in the software industry.Income Statement
ReposiTrak has demonstrated strong revenue growth with a consistent increase from previous periods, showcasing a positive trajectory in the software industry. The company maintains robust profitability with solid gross and net profit margins, indicating efficient cost management and strong market demand. EBIT and EBITDA margins further reflect operational efficiency. The overall income statement presents a stable and growing financial performance.85
Very Positive
Balance Sheet
The balance sheet of ReposiTrak is strong, with a high equity ratio reflecting a stable financial structure. The debt-to-equity ratio is low, indicating minimal reliance on debt for financing. Additionally, the high return on equity demonstrates the company's effective use of equity capital to generate profits. Overall, the balance sheet showcases financial stability and efficient capital management.90
Very Positive
Cash Flow
ReposiTrak's cash flow statement is positive, with strong operating cash flow and free cash flow indicating healthy liquidity. The free cash flow to net income ratio is favorable, suggesting efficient conversion of income into cash. The positive growth rate in free cash flow reflects the company's ability to generate cash from operations, supporting future growth and investment opportunities.78
Positive
| Breakdown | TTM | Dec 2025 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 22.61M | 22.61M | 20.45M | 19.10M | 18.05M | 21.01M |
| Gross Profit | 18.92M | 18.92M | 17.04M | 14.71M | 13.98M | 13.10M |
| EBITDA | 7.80M | 7.51M | 7.61M | 7.11M | 5.38M | 5.41M |
| Net Income | 6.98M | 6.98M | 5.96M | 5.59M | 4.00M | 4.12M |
Balance Sheet | ||||||
| Total Assets | 55.33M | 55.33M | 51.60M | 50.58M | 49.32M | 55.05M |
| Cash, Cash Equivalents and Short-Term Investments | 28.57M | 28.57M | 25.15M | 23.99M | 21.46M | 24.07M |
| Total Debt | 509.97K | 509.97K | 481.02K | 747.11K | 2.97M | 6.70M |
| Total Liabilities | 5.81M | 5.81M | 4.74M | 4.70M | 6.42M | 9.91M |
| Stockholders Equity | 49.52M | 49.52M | 46.85M | 45.88M | 42.90M | 45.14M |
Cash Flow | ||||||
| Free Cash Flow | 8.40M | 8.40M | 6.89M | 7.96M | 6.05M | 5.08M |
| Operating Cash Flow | 8.42M | 8.42M | 6.96M | 8.86M | 6.10M | 5.40M |
| Investing Cash Flow | 169.00 | 169.00 | -100.71K | -903.19K | 1.32M | -318.87K |
| Financing Cash Flow | -5.01M | -5.01M | -5.70M | -5.43M | -10.03M | -1.36M |
ReposiTrak Technical Analysis
Negative
14.92
Price Trends
16.67
Negative
18.57
Negative
19.69
Negative
Market Momentum
-0.38
Positive
34.78
Neutral
37.30
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TRAK, the sentiment is Negative. The current price of 14.92 is below the 20-day moving average (MA) of 16.77, below the 50-day MA of 16.67, and below the 200-day MA of 19.69, indicating a bearish trend. The MACD of -0.38 indicates Positive momentum. The RSI at 34.78 is Neutral, neither overbought nor oversold. The STOCH value of 37.30 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TRAK.
ReposiTrak Risk Analysis
ReposiTrak disclosed 26 risk factors in its most recent earnings report. ReposiTrak reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
ReposiTrak Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | $272.80M | 43.16 | 14.48% | 0.50% | 10.53% | 21.98% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
58 Neutral | $259.54M | ― | -25.48% | ― | -28.45% | -224.48% | |
56 Neutral | $236.49M | ― | -22.60% | ― | -6.88% | 15.83% | |
54 Neutral | $280.92M | ― | -18.25% | ― | -0.73% | 67.98% | |
53 Neutral | $265.55M | 1.51 | -10.56% | 10.83% | -17.17% | 497.89% | |
49 Neutral | $224.69M | ― | -28.14% | ― | 14.78% | 21.87% |
* Technology Sector Average
TRAK
ReposiTrak
14.92
-3.48
-18.91%
EGHT
8X8
2.06
0.08
4.04%
MKTW
MarketWise
15.70
5.21
49.67%
FRGE
Forge Global Holdings
16.52
-2.08
-11.18%
ONTF
ON24
5.70
-0.43
-7.01%
SMRT
SmartRent
1.38
-0.27
-16.36%
ReposiTrak Corporate Events
Dividends
ReposiTrak Announces Quarterly Dividend Increase
Positive
Jun 23, 2025
On June 20, 2025, ReposiTrak, Inc. announced a quarterly cash dividend of $0.01815 per share, payable on August 14, 2025, to shareholders of record on June 30, 2025. The company also revealed a 10% increase in its quarterly dividend, raising it to $0.02 per share starting with the dividend payable on November 14, 2025, marking the third increase since the dividend’s inception. This move underscores ReposiTrak’s commitment to providing value to its shareholders and may enhance its attractiveness to investors.
The most recent analyst rating on (TRAK) stock is a Buy with a $24.00 price target. To see the full list of analyst forecasts on ReposiTrak stock, see the TRAK Stock Forecast page.
DividendsBusiness Operations and StrategyFinancial Disclosures
ReposiTrak Reports 16% Revenue Increase in Q3 2025
Positive
May 19, 2025
ReposiTrak reported a 16% increase in total revenue, reaching $5.9 million for the third fiscal quarter ended March 31, 2025, with a 27% rise in net income. The company attributes this growth to successful cross-selling across its business lines, particularly in traceability, compliance, and supply chain solutions. The onboarding of traceability customers has shifted from retailers to suppliers, expanding the company’s market potential. The company also redeemed preferred shares and declared a quarterly dividend, maintaining a strong cash position with no bank debt.
The most recent analyst rating on (TRAK) stock is a Buy with a $24.00 price target. To see the full list of analyst forecasts on ReposiTrak stock, see the TRAK Stock Forecast page.
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.